Why the study?
Cardiac cachexia involves complex multisystem pathophysiology and accounts for difficult clinical management in chronic heart failure, with emerging evidence implicating several body systems.
This review highlights the pleiotropic mechanisms underlying cardiac cachexia in heart failure, emphasizing the intricate interplay between affected systems that complicates clinical management.
Answers are grounded in this paper and cite their sources.
Intertwined mechanisms complicate targeted management of cardiac cachexia; leaves open dominant therapeutic targets for prospective trials.
Cardiac cachexia is a muscle wasting process that often develops in those with chronic heart failure resulting in weight loss, low levels of physical activity, reduced quality of life, and is associated with a poor prognosis. The pathology of cardiac cachexia is complex with new evidence emerging that implicates several body systems. This review describes the pathophysiology associated with cardiac cachexia and addresses: 1) hormonal changes- neurohormonal abnormalities and metabolic hormone imbalance; 2) mechanisms of muscle wasting in cardiac cachexia, and the integral mechanisms between changed hormones due to cardiac cachexia and muscle wasting processes, and 3) associated abnormalities of gastrointestinal system that contribute to cardiac cachexia. These pleiotropic mechanisms demonstrate the intricate interplay between the affected systems and account for why cardiac cachexia is difficult to manage clinically. This review summarises current pathophysiology of cardiac cachexia and highlights symptoms of cardiac cachexia, implications for clinical practice and research gaps.
No takes yet. Share an insight, caveat, or question.
Thanapholsart et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: